Monthly Archives: July 2017

Patients do not feel involved in decisions about their own treatment: Results of the latest Adult Inpatient Survey by the Care Quality Commission

By Sharon Kell|2017-07-07T09:16:40+00:007 Jul 2017|Cancer news|

Results of the latest Adult Inpatient Survey by the Care [...]

Read More

Comments Off on Patients do not feel involved in decisions about their own treatment: Results of the latest Adult Inpatient Survey by the Care Quality Commission

• 

Combo immunotherapy doubles response rates and may herald a new standard of care

By Sharon Kell|2017-07-07T08:22:28+00:007 Jul 2017|Drug treatments|

Results from a recent phase II study published in the [...]

Read More

Comments Off on Combo immunotherapy doubles response rates and may herald a new standard of care

A test to gauge recurrence risk for kidney cancer is unable to predict which patients will benefit from adjuvant therapy

By Sharon Kell|2017-07-03T10:17:37+00:003 Jul 2017|Drug treatments|

An American company called Genomic Health has been collaborating with [...]

Read More

Comments Off on A test to gauge recurrence risk for kidney cancer is unable to predict which patients will benefit from adjuvant therapy

• 

Cancer Drugs Fund driving early access to promising new treatments

By Sharon Kell|2017-07-03T09:47:49+00:003 Jul 2017|Drug treatments|

The National Institute for Health and Care Excellence (NICE) has [...]

Read More

Comments Off on Cancer Drugs Fund driving early access to promising new treatments

• 

Office for National Statistics publishes latest cancer survival data

By Sharon Kell|2017-07-03T09:31:49+00:003 Jul 2017|Cancer news|

The Office for National Statistics (ONS) has published the latest [...]

Read More

Comments Off on Office for National Statistics publishes latest cancer survival data